Post by Arise News (@arisenews)

Novartis agrees to acquire Excellergy for up to $2 billion to boost immunology pipeline and expand US presence

Source: https://www.arise.tv/novartis-to-acquire-excellergy-in-2-billion-deal-to-expand-food-allergy-drug-portfolio

Novartis agrees to acquire Excellergy for up to $2 billion to boost immunology pipeline and expand U...

0 likes · 0 comments · 0 shares